Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy

Applied logistic regression

1990 • 37,000 citations

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

2002 • 5,471 citations

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension

1997 • 2,965 citations

Estimating Causal Effects from Large Data Sets Using Propensity Scores

1997 • 2,867 citations

An updated coronary risk profile. A statement for health professionals.

1991 • 1,878 citations

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials

2000 • 1,789 citations

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

2002 • 1,592 citations

Reversal of Left Ventricular Hypertrophy in Hypertensive Patients

1992 • 938 citations

Systolic versus diastolic blood pressure and risk of coronary heart disease

1971 • 915 citations

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension

1998 • 726 citations

Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy.

1994 • 623 citations

Correction of Arterial Structure and Endothelial Dysfunction in Human Essential Hypertension by the Angiotensin Receptor Antagonist Losartan

2000 • 613 citations

Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?

1998 • 565 citations

Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings.

1987 • 559 citations

Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study

1981 • 431 citations

Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products

1995 • 389 citations

Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials

1986 • 363 citations

Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment

1995 • 330 citations

Discussion

1997 • 315 citations

Characteristics of 9194 Patients With Left Ventricular Hypertrophy

1998 • 296 citations

Left Ventricular Hypertrophy as an Independent Predictor of Acute Cerebrovascular Events in Essential Hypertension

2001 • 277 citations

Mortality in Patients of the Glasgow Blood Pressure Clinic

1986 • 268 citations

Improved electrocardiographic diagnosis of left ventricular hypertrophy

1994 • 239 citations

Cardiovascular Morbidity in Relation to Change in Blood Pressure and Serum Cholesterol Levels in Treated Hypertension

1987 • 188 citations

Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials

1996 • 174 citations

Stroke is More Common than Myocardial Infarction in Hypertension: Analysis based on 11 Major Randomized Intervention Trials

2001 • 116 citations

Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: results of a correlated data base approach

1995 • 115 citations

Angiotensin II Receptor Antagonists: An Emerging New Class of Cardiovascular Therapeutics.

1999 • 103 citations

Electrocardiographic identification of left ventricular hypertrophy: Test performance in relation to definition of hypertrophy and presence of obesity

1996 • 101 citations

Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension*

1995 • 101 citations

High Risk of Cerebro‐cardiovascular Morbidity in Well Treated Male Hypertensives

1984 • 83 citations

Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease

2001 • 69 citations

Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: The LIFE study

2000 • 60 citations